非结合性高 bilirubinemia可能会加剧某些潜在的慢性肝病
Roman Dascal1, Julia Uhanova1, Gerald Y Minuk1,2
1Section of Hepatology, Department of Medicine, Winnipeg, Manitoba, Canada.
Canadian liver journal
|December 25, 2023
概括
慢性肝病 (CLD) 患者的非结合性高 bilirubinemia (UCB) 与肝炎和纤维化增加有关,与此前在其他炎症条件中的发现相反. 这项研究强调了UCB与特定的CLD疾病的疾病严重程度之间的潜在关联.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
背景情况:
- 之前的研究表明,高的非结合性胆红素和慢性炎症疾病之间存在负相关性.
- 未结合性高 bilirubinemia (UCB) 和慢性肝病 (CLD) 之间的联系以前没有被调查.
研究的目的:
- 评估有或没有UCB的CLD患者的肝脏死炎性疾病活性和纤维化.
- 为了确定UCB是否与CLD中肝病标志物增加或减少有关.
主要方法:
- 用血清氨基转移酶水平来评估死炎活性.
- 计算APRI和FIB-4得分以评估纤维化.
- 根据年龄,性别和CLD类型,UCB患者与对照人群进行1:2匹配.
主要成果:
- 在9745名CLD患者中,有208名 (2.1%) 患有UCB,对照组399人.
- 在UCB患者中,氨基转移酶水平,APRI和FIB-4得分显著提高.
- 这种关联在慢性病毒和免疫媒介性肝脏疾病中很突出,而不是NAFLD,ALD或"其他"CLD.
结论:
- 在特定的CLD中,UCB与肝脏死炎活动和纤维化有关.
- 这些发现挑战了之前观察到的UCB与其他疾病中的炎症之间的反向关系.
- 需要进一步的研究来阐明UCB在CLD进展中的作用背后的机制.
相关概念视频
Diseases of the Liver and Gallbladder
555
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
555
Chronic Bowel Disorders: Introduction
456
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
456
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
Inflammatory Bowel Disease I: Ulcerative Colitis
188
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
188
Hepatic Drug Excretion: Influencing Factors
131
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
131
Factors Influencing Drug Absorption: Disease States and Pharmacology
523
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
523


